Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PIM2 Antikörper (AA 1-210)

This anti-PIM2 antibody (ABIN7169145) is a Rabbit Polyclonal antibody detecting PIM2 in IHC, ELISA, IF. Suitable for Human.
Produktnummer ABIN7169145

Kurzübersicht für PIM2 Antikörper (AA 1-210) (ABIN7169145)

Target

Alle PIM2 Antikörper anzeigen
PIM2 (Proto-Oncogene Pim-2 (Serine Threonine Kinase) (PIM2))

Reaktivität

  • 49
  • 10
  • 7
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 44
  • 8
  • 2
  • 1
Kaninchen

Klonalität

  • 43
  • 12
Polyklonal

Konjugat

  • 40
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser PIM2 Antikörper ist unkonjugiert

Applikation

  • 42
  • 31
  • 27
  • 16
  • 13
  • 8
  • 5
  • 4
  • 1
  • 1
Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
  • Bindungsspezifität

    • 9
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-210

    Kreuzreaktivität

    Human

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Serine/threonine-protein kinase pim-2 protein (1-210AA)

    Isotyp

    IgG
  • Applikationshinweise

    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    PIM2 (Proto-Oncogene Pim-2 (Serine Threonine Kinase) (PIM2))

    Andere Bezeichnung

    PIM2

    Hintergrund

    Background: Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression, the regulation of cap-dependent protein translation and through survival signaling by phosphorylation of a pro-apoptotic protein, BAD. Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase transcriptional activity. The stabilization of MYC exerted by PIM2 might explain partly the strong synergism between these 2 oncogenes in tumorigenesis. Regulates cap-dependent protein translation in a mammalian target of rapamycin complex 1 (mTORC1)-independent manner and in parallel to the PI3K-Akt pathway. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Promotes cell survival in response to a variety of proliferative signals via positive regulation of the I-kappa-B kinase/NF-kappa-B cascade, this process requires phosphorylation of MAP3K8/COT. Promotes growth factor-independent proliferation by phosphorylation of cell cycle factors such as CDKN1A and CDKN1B. Involved in the positive regulation of chondrocyte survival and autophagy in the epiphyseal growth plate.

    Aliases: OTTHUMP00000025825 antibody, Pim 2 oncogene antibody, Pim 2h antibody, Pim-2h antibody, PIM2 antibody, PIM2 Oncogene antibody, PIM2_HUMAN antibody, Pim2h antibody, Proto Oncogene PIM2 antibody, Proto-oncogene Pim-2 (serine threonine kinase) antibody, Serine/threonine kinase PIM2 antibody, Serine/threonine-protein kinase Pim-2 antibody

    UniProt

    Q9P1W9
Sie sind hier:
Chat with us!